XERION PHARMACEUTICALS AG has a total of 21 patent applications. Its first patent ever was published in 1998. It filed its patents most often in EPO (European Patent Office), Australia and Canada. Its main competitors in its focus markets pharmaceuticals, biotechnology and organic fine chemistry are CRC FOR BIOPHARMACEUTICAL RESE, U3 PHARMA AG and RIBOVAX BIOTECHNOLOGIES S A.
# | Country | Total Patents | |
---|---|---|---|
#1 | EPO (European Patent Office) | 8 | |
#2 | Australia | 3 | |
#3 | Canada | 3 | |
#4 | China | 3 | |
#5 | WIPO (World Intellectual Property Organization) | 3 | |
#6 | Germany | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology | |
#3 | Organic fine chemistry | |
#4 | Measurement | |
#5 | Environmental technology |
# | Technology | |
---|---|---|
#1 | Therapeutic chemical compounds | |
#2 | Peptides | |
#3 | Medical preparations | |
#4 | Microorganisms | |
#5 | Combinatorial chemistry | |
#6 | Analysing materials | |
#7 | Climate change adaptation technologies |
# | Name | Total Patents |
---|---|---|
#1 | Zehetmeier Carolin | 15 |
#2 | Unger Christine Margarete | 14 |
#3 | Torella Claudia | 14 |
#4 | Beste Gerald | 14 |
#5 | Jay Daniel G | 7 |
#6 | Eustace Brenda K | 7 |
#7 | Lain Blanca | 7 |
#8 | Niewoehner Jens | 5 |
#9 | Knauer Roland | 5 |
#10 | Ahrens Bianca | 4 |
Publication | Filing date | Title |
---|---|---|
CN1777622A | Modulation of the poliovirus receptor function | |
EP1481993A1 | Modulation of the poliovirus receptor function | |
EP1439192A1 | Neuropilin-1 inhibitors | |
EP1382615A1 | MCAM inhibitors | |
DE19802576A1 | Methods for the simultaneous identification of proteins and their binding partners |